Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Viruses ; 12(4)2020 04 19.
Artigo em Inglês | MEDLINE | ID: mdl-32325896

RESUMO

Human noroviruses are the leading cause of foodborne gastroenteritis worldwide and disease outbreaks have been linked to contaminated surface waters as well as to produce consumption. Noroviruses are extremely stable in water and their presence is being detected with increasing frequency, yet there are no viable methods for reducing norovirus contamination in environmental water. Despite this, there is little knowledge regarding the physical and chemical factors that influence the environmental persistence of this pathogen. This study evaluated the impact of common chemical and physical properties of surface water on the stability of murine norovirus and examined the effect of food-safe chitosan microparticles on infectivity of two human norovirus surrogates. While chemical additives had a minor impact on virus survival, chitosan microparticles significantly reduced infectious titers of both murine norovirus and MS2 bacteriophage.


Assuntos
Antivirais/farmacologia , Infecções por Caliciviridae/virologia , Gastroenterite/virologia , Norovirus/efeitos dos fármacos , Norovirus/fisiologia , Animais , Antivirais/uso terapêutico , Biomarcadores , Infecções por Caliciviridae/diagnóstico , Infecções por Caliciviridae/tratamento farmacológico , Linhagem Celular , Terapia Combinada , Desenvolvimento de Medicamentos , Gastroenterite/diagnóstico , Gastroenterite/tratamento farmacológico , Humanos , Camundongos , Viabilidade Microbiana/efeitos dos fármacos , Temperatura , Ensaio de Placa Viral
2.
PLoS Pathog ; 9(9): e1003592, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24039576

RESUMO

Whether or not primary norovirus infections induce protective immunity has become a controversial issue, potentially confounded by the comparison of data from genetically distinct norovirus strains. Early human volunteer studies performed with a norovirus-positive inoculum initially led to the conclusion that primary infection does not generate long-term, protective immunity. More recently though, the epidemiological pattern of norovirus pandemics has led to the extrapolation that primary norovirus infection induces herd immunity. While these are seemingly discordant observations, they may in fact reflect virus strain-, cluster-, or genogroup-specific differences in protective immunity induction. Here, we report that highly genetically related intra-cluster murine norovirus strains differ dramatically in their ability to induce a protective immune response: Primary MNV-3 infection induced robust and cross-reactive protection, whereas primary MNV-1 infection induced modest homotypic and no heterotypic protection. In addition to this fundamental observation that intra-cluster norovirus strains display remarkable differences in protective immunity induction, we report three additional important observations relevant to norovirus:host interactions. First, antibody and CD4⁺ T cells are essential to controlling secondary norovirus infections. Second, the viral minor structural protein VP2 regulates the maturation of antigen presenting cells and protective immunity induction in a virus strain-specific manner, pointing to a mechanism by which MNV-1 may prevent the stimulation of memory immune responses. Third, VF1-mediated regulation of cytokine induction also correlates with protective immunity induction. Thus, two highly genetically-related norovirus strains displayed striking differences in induction of protective immune responses, strongly suggesting that the interpretation of norovirus immunity and vaccine studies must consider potential virus strain-specific effects. Moreover, we have identified immune (antibody and CD4⁺ T cells) and viral (VP2 and possibly VF1) correlates of norovirus protective immunity. These findings have significant implications for our understanding of norovirus immunity during primary infections as well as the development of new norovirus vaccines.


Assuntos
Linfócitos T CD4-Positivos/imunologia , Infecções por Caliciviridae/imunologia , Proteínas do Capsídeo/imunologia , Memória Imunológica , Norovirus/imunologia , Animais , Células Apresentadoras de Antígenos/imunologia , Infecções por Caliciviridae/genética , Infecções por Caliciviridae/prevenção & controle , Proteínas do Capsídeo/genética , Linhagem Celular , Citocinas/genética , Citocinas/imunologia , Humanos , Camundongos , Camundongos Knockout , Norovirus/genética , Especificidade da Espécie , Vacinas Virais/genética , Vacinas Virais/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA